A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)
Phase of Trial: Phase IV
Latest Information Update: 31 Oct 2018
Price : $35 *
At a glance
- Drugs Donepezil (Primary)
- Indications Lewy body disease
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 27 Aug 2018 Status changed from active, no longer recruiting to completed.
- 28 Dec 2017 Planned End Date changed from 1 May 2018 to 1 May 2019.
- 28 Dec 2017 Planned primary completion date changed from 1 Feb 2018 to 1 May 2018.